Tag: #Global Trends

Rival European pharmaceutical companies Sanofi and GSK have both forged new partnership agreements aimed at strengthening their respective preclinical research... Read more

Novartis has announced favorable outcomes from the Phase III clinical trial VAYHIT2, which assessed the efficacy of ianalumab combined with... Read more

Paradigm Health has completed the acquisition of Flatiron Health's clinical research business shortly after successfully raising $78 million in a... Read more

The American pharmaceutical giant, Eli Lilly, has designated Huntsville, Alabama, as the location for its third manufacturing facility dedicated to... Read more

Relation Therapeutics has announced the formation of a multi-program, strategic alliance with Novartis with the aim of accelerating the development... Read more

Licensing Agreement Details Pfizer, the U.S.-based pharmaceutical manufacturer, has signed an exclusive licensing deal with Yao Pharma—a subsidiary of Fosun... Read more

Relation Therapeutics has announced the formation of a multi-program, strategic alliance with Novartis with the aim of accelerating the development... Read more

On December 9, 2025, a major pharmaceutical corporation based in New York announced it had entered into an exclusive global... Read more

(ASH Congress) – AstraZeneca (AZ) announced positive clinical data for its leading cell therapy candidate, AZD0120 (formerly GC012F), for the... Read more